Targeting one side of the brain may help restore memory in Alzheimer's disease

Researchers found that regulating a specific receptor in the left hippocampus can improve memory in mouse models of Alzheimer's disease.

Scientists found that the left hippocampus is a critical site for memory dysfunction in Alzheimer's disease. Selective inhibition of mGlu5 in the left side of the brain restores working and short-term memory in mice.

Researchers studied mGlu5, which is a metabotropic glutamate receptor essential for synaptic plasticity and memory. They used two mouse models of Alzheimer's disease called J20 and 5xFAD. In healthy mice, mGlu5 expression is higher in the left hemisphere. This physiological asymmetry is lost in the J20 and 5xFAD mice.

The team used Alloswitch-1, a light-controllable negative allosteric modulator. This tool allowed them to inhibit mGlu5 selectively in the left hippocampus. This left-specific modulation also normalizes pathological downstream signaling. This includes aberrant Pyk2 and GSK-3β activation and tau hyperphosphorylation across both hemispheres.

The findings indicate that altered mGlu5 expression is a dysregulated signaling state. This state remains functionally relevant and pharmacologically targetable. This research highlights the therapeutic potential of region-specific photopharmacology for precise intervention in early Alzheimer's disease pathology.

Key facts

  • mGlu5 expression is naturally higher in the left hippocampus of wild-type mice.
  • The J20 and 5xFAD mouse models lose this left-right asymmetry.
  • Inhibiting mGlu5 in the left hippocampus restores working and short-term memory in Alzheimer's mice.
  • Left-specific modulation normalizes tau hyperphosphorylation across both hemispheres.

All sections

Edition